These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 8564934)

  • 1. Nuclear localization of procathepsin L/MEP in ras-transformed mouse fibroblasts.
    Hiwasa T; Sakiyama S
    Cancer Lett; 1996 Jan; 99(1):87-91. PubMed ID: 8564934
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multiple processing of procathepsin L to cathepsin L in vivo.
    Ishidoh K; Saido TC; Kawashima S; Hirose M; Watanabe S; Sato N; Kominami E
    Biochem Biophys Res Commun; 1998 Nov; 252(1):202-7. PubMed ID: 9813170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Co-localization of ras gene products and cathepsin L in cytoplasmic vesicles in v-Ha-ras-transformed NIH3T3 mouse fibroblasts.
    Hiwasa T; Sawada T; Tanaka K; Chiba T; Tanaka T; Kominami E; Katunuma N; Sakiyama S
    Biomed Biochim Acta; 1991; 50(4-6):579-85. PubMed ID: 1801726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of cathepsins L and B and decreased activity of their inhibitors in metastatic, ras-transformed NIH 3T3 cells.
    Chambers AF; Colella R; Denhardt DT; Wilson SM
    Mol Carcinog; 1992; 5(3):238-45. PubMed ID: 1586450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Physical association of Ras and cathepsins B and L in the conditioned medium of v-Ha-ras-transformed NIH3T3 cells.
    Hiwasa T; Kominami E
    Biochem Biophys Res Commun; 1995 Nov; 216(3):828-34. PubMed ID: 7488200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Procathepsin L-specific antibodies that recognize procathepsin L but not cathepsin L.
    Ishidoh K; Takeda-Ezaki M; Kominami E
    FEBS Lett; 1993 May; 322(1):79-82. PubMed ID: 8482373
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of carboxy-terminal amino acids in secretion of human lysosomal protease cathepsin L.
    Chauhan SS; Ray D; Kane SE; Willingham MC; Gottesman MM
    Biochemistry; 1998 Jun; 37(23):8584-94. PubMed ID: 9622510
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multi-step processing of procathepsin L in vitro.
    Ishidoh K; Kominami E
    FEBS Lett; 1994 Oct; 352(3):281-4. PubMed ID: 7925987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An alternate targeting pathway for procathepsin L in mouse fibroblasts.
    Ahn K; Yeyeodu S; Collette J; Madden V; Arthur J; Li L; Erickson AH
    Traffic; 2002 Feb; 3(2):147-59. PubMed ID: 11929604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose controls cathepsin expression in Ras-transformed fibroblasts.
    Tournu C; Obled A; Roux MP; Deval C; Ferrara M; Béchet DM
    Arch Biochem Biophys; 1998 Dec; 360(1):15-24. PubMed ID: 9826424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Developmental expression of cathepsin L and c-rasHa in the mouse placenta.
    Hamilton RT; Bruns KA; Delgado MA; Shim JK; Fang Y; Denhardt DT; Nilsen-Hamilton M
    Mol Reprod Dev; 1991 Dec; 30(4):285-92. PubMed ID: 1751032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence that aspartic proteinase is involved in the proteolytic processing event of procathepsin L in lysosomes.
    Nishimura Y; Kawabata T; Furuno K; Kato K
    Arch Biochem Biophys; 1989 Jun; 271(2):400-6. PubMed ID: 2658811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse procathepsin L lacking a functional glycosylation site is properly folded, stable, and secreted by NIH 3T3 cells.
    Kane SE
    J Biol Chem; 1993 May; 268(15):11456-62. PubMed ID: 8496193
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of cathepsin L synthesized by normal and transformed cells at the gene, message, protein, and oligosaccharide levels.
    Stearns NA; Dong JM; Pan JX; Brenner DA; Sahagian GG
    Arch Biochem Biophys; 1990 Dec; 283(2):447-57. PubMed ID: 2275556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. v-Ha-Ras insertion/deletion mutants with reduced protease-inhibitory activity have no transforming activity.
    Sawada T; Sakiyama S; Hiwasa T
    FEBS Lett; 1993 Mar; 318(3):297-300. PubMed ID: 8440385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Increased expression and activity of nuclear cathepsin L in cancer cells suggests a novel mechanism of cell transformation.
    Goulet B; Sansregret L; Leduy L; Bogyo M; Weber E; Chauhan SS; Nepveu A
    Mol Cancer Res; 2007 Sep; 5(9):899-907. PubMed ID: 17855659
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucose regulates protein catabolism in ras-transformed fibroblasts through a lysosomal-dependent proteolytic pathway.
    Tournu C; Obled A; Roux MP; Ferrara M; Omura S; Béchet DM
    Biochem J; 2001 Jul; 357(Pt 1):255-61. PubMed ID: 11415457
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of cathepsin L in malignant transformation.
    Kane SE; Gottesman MM
    Semin Cancer Biol; 1990 Apr; 1(2):127-36. PubMed ID: 2103489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cloning and characterization of anti-cathepsin L single chain variable fragment whose expression inhibits procathepsin L secretion in human melanoma cells.
    Guillaume-Rousselet N; Jean D; Frade R
    Biochem J; 2002 Oct; 367(Pt 1):219-27. PubMed ID: 12241546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycosylation of procathepsin L does not account for species molecular-mass differences and is not required for proteolytic activity.
    Smith SM; Kane SE; Gal S; Mason RW; Gottesman MM
    Biochem J; 1989 Sep; 262(3):931-8. PubMed ID: 2480110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.